Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride Capsule
Product Images NDC 49884-151

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bismuth Subcitrate Potassium, Metronidazole And Tetracycline Hydrochloride (NDC 49884-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Metronidazole-stru-formula (Bismuth Subcitrate Potassium Metronidazole And Tet 1)

Chemical structure diagram of metronidazole, showing its molecular framework with labeled functional groups. The image includes the molecular weight of 171.2 displayed below the diagram.*

FDA Label Image

Tetracycline-stru-formula (Bismuth Subcitrate Potassium Metronidazole And Tet 2)

Chemical structure diagram showing the molecular structure of Tetracycline Hydrochloride with a molecular weight of 480.90 as labeled in the image. The diagram includes atomic symbols and bond representations for the compound.*

FDA Label Image

Bmt Capsules (Bismuth Subcitrate Potassium Metronidazole And Tet 3)

Label for Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline Hydrochloride capsules, each containing 140 mg, 125 mg, and 125 mg respectively. The label indicates a blister pack containing 3 capsules, distributed by Par Pharmaceutical, made in India with NDC 49884-151-24. The label includes dosage instructions, barcode, and space for lot and expiration dates.*

FDA Label Image

Bmt Capsules (Bismuth Subcitrate Potassium Metronidazole And Tet 4)

Box packaging label for Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride Capsules, 140 mg/125 mg/125 mg strength. The label states it is a 10 Day Therapy PAK containing 120 capsules in 10 blister cards, each with 3 capsules. Distributed by Par Pharmaceutical, manufactured by Par Formulations Private Limited in India. Dosage instructions and ingredients are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.